Josip Pavan
University Hospital Dubrava
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Josip Pavan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:16 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06969586 · The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal DystrophyUniversity Hospital Dubrava · enrolling by invitation · Fuchs Endothelial Corneal Dystrophy, Cataract, Glaucoma · study director
- Ph2/Ph3NCT06960629 · The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)University Hospital Dubrava · completed · Pseudophakic Bullous Keratopathy, Glaucoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:16 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)-Randomized Controlled Trial.Medicina (Kaunas) · 20225 citationsRCR 0.7
- Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in Croatia.Methods Find Exp Clin Pharmacol · 20103 citationsRCR 0.1
- Effectiveness of latanoprost (Xalatan) monotherapy in newly discovered and previously medicamentously treated primary open angle glaucoma patients.Coll Antropol · 20052 citationsRCR 0.1